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Abstract: Lipid profiles of seven human breast milk samples obtained from milk banks and four infant formulas were 
compared in view of the potential food hypersensitivities of certain infants to human milk.The cholesterol (0.15-0.26 mM) 
content of the human samples was about 50% lower than that found in the infant formulas whereas the triglyceride (TG, 
173-386 mM) contents of these products were found to be comparable.The major saturated fatty acid (SFA) and mono-
unsaturated fatty acid (MUFA) were 16:0 and 18:1 respectively. The major poly-unsaturated fatty acid (PUFA) was 18:2 
with other PUFA members of the C18, C20 and C22 families identified and quantified. Although conjugated linoleic acid 
(CLA) was not detected in any infant formulas tested, no other major differences in the fatty acid patterns were found. 
However, the mean (13.6) of the ratio of n-6 PUFAs/n-3 PUFAs in the human milk samples was about 50% higher than 
that observed in the infant formula samples.Although our results indicate that there are small yet significant differences in 
cholesterol and CLA content and the ratio of n-6 PUFAs/n-3PUFAs, the lipid composition of milk bank breast milk and 
infant formulas is quite comparable. 
Keywords: cholesterol,CLA, fatty acids, human, milk, PUFA, triglycerides. 
INTRODUCTION 
 Milk has long been an essential component in human 
nutrition. Newborns totally depend on “mothers’ milk” for 
their sustenance and according to the World Health Organi-
zation, breast feeding for the first six months is advantageous 
to the infant’s development and long-term health status [1]. 
However, under certain circumstances breast-feeding is ei-
ther impractical or undesirable, e.g for premature infants, 
special needs infants or the mother’s medical condition, and 
mothers who still want to provide human milk for their in-
fants have turned to human milk banks since wet nurses are 
no longer in vogue.To prevent disease transmission, human 
milk banks screen donor milk for various diseases prior to 
distribution. Other mothers have opted for infant formulas to 
feed their babies as these commercial products are easily 
accessible and manufactured to conform to certain standards. 
Obviously each nutritional option (milk bank or commercial 
formula) represents different benefits and risks [2, 3].  
 Both human milk and infant formula contain milk tri-
glycerides as the major source of energy in addition to other 
essential nutrients for infants. A number of studies have ex-
amined the lipid profiles of human milk samples [4-6] and 
several studies have compared the lipid composition of hu-
man milk and infant formulas [7-9]. In most of these studies, 
milk samples were collected at different post-partum stages 
and immediately frozen and stored prior to analyses.  
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However, milk banks only use mature breast milk and rou-
tinely pasteurize donor milk samples prior to distribution [2]. 
Since we are not aware of any reports concerning milk lipid 
analyses from samples obtained from milk banks, we carried 
out the present study and compared the lipid composition of 
pasteurized breast milk from human milk banks and several 
infant formulas in order to determine which milk group 
might be a better lipid source for infant nutrition. 
EXPERIMENTAL SECTION 
 All infant formulas used in this study were purchased 
from local grocery stores. The infant formulas purchased 
were Enfamil LIPIL® infant formula, Nestle Good Start Gen-
tle Plus® formula, Similac Advance Early shield® infant for-
mula and SimilacIsomil Advance® soy formula. The human 
breast milk samples were obtained either from the Mothers’ 
Milk Bank (Raleigh, NC) or the Breastfeeding Center of 
Greater Washington (DC). Approval for the use of human 
subjects was obtained from the Office of Human Research, 
The George Washington University, and informed consent 
was obtained from the donors. 
 Triglyceride (TG) analyses were carried out using the 
Triglyceride Infinity reagent TR 22321 (Thermo Fisher Sci-
entific, Inc., Atlanta, GA) according to the protocol de-
scribed in reagent technical bulletin. Cholesterol quantitation 
was determined using the fluorogenicAmplex Red cholester-
ol assay kit (A12216) obtained from Invitrogen (Carlsbad, 
CA) following the procedure described in the kit bulletin. 
GLC analyses were carried out with a helium carrier gas on a 
Supelcowax 10 fused silica capillary GLC column # 24081 
(60m x 0.25 mm ID, 0.25 μm, Supelco, Inc. Bellefonte, PA). 
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The column was attached to a Shimadzu GC 14A chromato-
graph connected to a Shimadzu CR8A Chromatopac data 
processor (Shimadzu Scientific Instruments, Inc., Columbia, 
MD). In order to determine the fatty acid content of the milk 
samples, the milk lipids were first extracted using the Folch 
extraction method [10] and then transmethylated using the 
sodium methoxide approach [11]. The fatty acid methyl es-
ters (FAMEs)were analyzed using injector and flame ioniza-
tion detector temperatures set at 250o C. Two different col-
umn temperature programs were run for each sample: pro-
gram 1 started at 100o C for 1 min, then 100o to 210o C (10 
min), 210o C (60 min), 210o to 240o C (5 min) and 240o C for 
5 min; program 2 started at 65o C, then 65o to 195o C (10 
min), 195o C (20 min), 195o to 240o C (3 min) and 240o C for 
75 min [11]. A known amount of 13:0 methyl ester was used 
as an internal standard for all GLC analyses as separate ex-
periments had shown the absence of this FAME in all origi-
nal milk samples. GLC reference FAME standard mixtures # 
461, 538, 606 and some individual FAMEs were obtained 
from Nu-Chek Prep, Inc. (Elysian, MN) to confirm the iden-
tities of the FAME components in the milk samples. Each 
sample was analyzed at least twice to ensure reproducibility. 
RESULTS 
 As shown in Table 1, the cholesterol content of seven 
human breast milk samples obtained from milk banks ranged 
from 0.155 to 0.265 mM (mean 0.219 mM) whereas the cho-
lesterol content of the infant formulas was about 50% higher 
(p<0.05) and ranged from 0.250-0.385mM (mean 0.318 
mM). The TG concentrations of the seven human donors 
varied from 173 to 386 mM(mean 292 mM) which was 
comparable to the TG content range of the infant formulas, 
228-297 mM (mean 274 mM). 
 
 The fatty acid profiles of human breast milk samples 
from seven donors and four different baby formulas are pre-
sented in Tables 2 and 3. In general, a number of qualitative 
similarities between these groups were observed. For exam-
ple, the major saturated fatty acid (SFA) and mono-
unsaturated fatty acid (MUFA) are palmitic acid and 
octadecenoic acids respectively. In human breast milk, the 
palmitic acid content ranged from 18.4-28.0 mole % (mean 
22.8%) and in infant formula from 8.81-24.4 %. The 
octadecenoic acid content in human breast milk ranged from 
35.4-50.7% (median 40.5 %) and in baby formulas from 
37.0-46.1%. The major poly-unsaturated fatty acid (PUFA) 
present in all these samples is linoleic acid with lesser 
amounts of 18:3(n-3). In the human donors, the linoleic acid 
content ranged from 14.2-22.1 % (mean 18.0 %) and in in-
fant formulas, the range was from 17.6-23.7%. The PUFA 
family with the highest mole % was the C18 and included 
18:2 (n-6), 18:3 (n-6), 18:3 (n-3) and conjugated linoleic 
acid (CLA). In human breast milk samples, the total C18 
PUFA mole % ranged from 16.1-24.4 % (mean 19.6%) and 
in infant formula, from 19.3-25.9% (Table 4). For all milk 
samples, the relative mole % content for the three PUFA 
families was in the order of C18>>C20>C22 (Table 4). No 
CLA isomers were detected in any of the infant formulas. 
 When the ratios of (SFA+MUFA)/PUFA were deter-
mined, the human milk samples [ratios ranged from 2.78-
4.64 (mean 3.78)] were comparable to those calculated for 
the infant formula samples [ratios varied from 2.72-3.84 
(mean 3.15), Table 4]. The ratio of n-6 PUFA/n-3 PUFA is 
generally utilized to determine the balance between essential 
fatty acids. As shown in Table 4, this ratio varied from 7.63-
20.1 for seven human donors and from 9.00-9.64 for infant 
formula samples. The mean (13.6) of this n-6/n-3 ratio for 
human donors was significantly higher (p<0.05) than the 
corresponding mean (9.35) observed for the formula sam-
ples. 
 
Table 1. Cholesterol and TG Levels in Milk Samples from Human Breast and Infant Formulas. Cholesterol and TG Analyses were 
Carried Out as Described in Materials and Methods. Data are mean + SD (n) where n is the number of analyses Carried 
Out 
Source Cholesterol (mM) Triglycerides (mM) 
Human 
Subject 1 0.252 + 0.037 (2) 364 + 80 (4) 
Subject 2 0.235 + 0.035 (2) 273 + 72 (4) 
Subject 3 0.215 +0.025 (2) 278 + 66 (4) 
Subject 4 0.192 +0.038 (2) 173 + 10 (4) 
Subject 5 0.265 +0.045 (2) 386 + 73 (4) 
Subject 6 0.217 +0.052 (2) 275 + 37 (4) 
Subject 7 0.155 +0.005 (2)  
Infant Formula 
Enfamil 0.250 + 0.050 (2) 278 + 13 (4) 
Goodstart 0.337 + 0.023 (2) 291 + 13 (4) 
Similac 0.300 + 0.050 (2) 228 + 44 (4) 
Simlc/Isomil 0.385 + 0.045 (2) 297 + 15 (4) 
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Table 2. Fatty Acid Composition of Lipids Extracted from Human Breast Milk. After Extraction, Lipids were Trans-esterified to 
Fatty Acid Methyl Esters and Analyzed by Capillary GLC as Described in Materials and Methods. Data are Expressed as 
Mole % and are the Average of at Least two Separate Determinations 
Donor 1 2 3 4 5 6 7 
FA mole % mole % mole % mole % mole % mole % mole % 
10:0 0.760 0.715 0.965 0.581 0.904 0.395 1.560 
12:0 3.241 3.860 4.607 2.519 5.122 4.228 5.318 
14:0 4.423 6.020 5.490 3.070 5.425 6.024 5.055 
14:1 0.168 0.3012 0.165 0.097 0.056 0.127 0.158 
15:0 0.309 0.482 0.265 0.236 0.268 0.325 0.240 
16:0 28.002 23.474 22.025 18.379 21.327 25.621 20.800 
16:1 2.166 3.078 2.239 1.270 1.985 1.121 1.856 
17:0 0.313 0.408 0.291 0.256 0.268 0.342 0.341 
17:1 0.219 0.276 0.252 0.154 0.185 0.181 0.196 
18:0 1.122 0.990 2.510 1.040 3.604 1.068 1.069 
18:1 38.766 39.844 40.691 50.692 35.449 41.945 36.289 
20:0 0.384 0.199 0.345 0.281 0.307 0.270 0.235 
20:1 0.432 0.323 0.419 0.446 0.391 0.465 0.348 
22:1 0.062 0.042 0.058 0.052 0.075 0.088 0.055 
23:0 0.014 0.013 0.018 0.012 0.018 0.010 0.014 
24:1 0.055 0.024 0.019 0.023 0.067 0.056 0.024 
Σ SFA+MUFA 80.436 80.049 80.359 79.109 75.451 82.265 73.558 
18:2 (n-6) 16.850 17.122 16.637 18.565 20.794 14.234 22.140 
18:3 (n-6) 0.104 0.124 0.241 0.133 0.160 0.134 0.233 
18:3 (n-3) 1.150 1.069 0.811 0.773 1.259 1.636 1.847 
CLA 0.189 0.345 0.189 0.163 0.180 0.122 0.147 
20:2 (n-6) 0.311 0.248 0.276 0.234 0.407 0.216 0.280 
20:3 (n-6) 0.317 0.352 0.517 0.269 0.447 0.341 0.377 
20:4 (n-6) 0.219 0.276 0.442 0.329 0.375 0.364 0.587 
20:3 (n-3) 0.029 0.036 0.025 0.021 0.058 0.037 0.041 
20:5 (n-3) / 22:0 0.100 0.101 0.152 0.147 0.175 0.137 0.191 
22:2 (n-6) 0.032 0.026 0.028 0.026 0.061 0.024 0.031 
22:4 (n-6) 0.055 0.063 0.090 0.057 0.083 0.076 0.097 
22:5(n-6) 0.019 0.022 0.032 0.023 0.034 0.034 0.020 
22:5 (n-3)/ 24:0 0.082 0.109 0.125 0.095 0.222 0.198 0.205 
22:6 (n-3) 0.108 0.054 0.081 0.063 0.294 0.181 0.249 
Σ PUFA 19. 565 19.947 19.646 20.898 24.549 17.734 26.445 
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Table 3. Fatty Acid Composition of Lipids Extracted from Several Infant Formula Samples. See Legend to Table 2 for Explana-
tion. 1Not Detected 
Formula Goodstart Enfamil SmlcBaby SmlcIso 
FA mole % mole% mole% mole% 
10:0 0.463 0.890 0.647 0.743 
12:0 8.482 7.827 11.340 11.147 
14:0 4.569 4.423 5.693 5.167 
15:0 nd1 0.114 nd nd 
16:0 24.361 24.344 8.809 8.478 
16:1 0.201 0.173 0.105 0.107 
17:0 0.096 0.093 nd 0.079 
18:0 0.590 0.528 0.725 0.599 
18:1 37.014 40.379 45.786 46.114 
20:0 0.339 0.333 0.306 0.329 
20:1 0.178 0.193 0.214 0.231 
22:1 0.018 0.008 0.013 0.043 
23:0 0.029 0.033 0.027 0.028 
24:1 0.015 nd 0.059 0.062 
Σ SFA+MUFA 76.356 79.338 73.723 73.127 
          
18:2 (n-6) 20.392 17.617 23.098 23.688 
18:3 (n-6) 0.089 0.07 0.115 0.030 
18:3 (n-3) 1.948 1.606 2.173 2.189 
CLA nd nd nd nd 
20:2 (n-6) 0.022 0.009 0.010 0.013 
20:3 (n-6) 0.054 0.055 0.043 0.031 
20:4 (n-6) 0.582 0.626 0.340 0.335 
20:3(n-3) nd 0.005 nd 0.003 
22:0/20:5 0.166 0.256 0.239 0.252 
22:2 (n-6) 0.035 0.029 0.024 0.025 
22:4 (n-6) nd nd nd 0.005 
22:5(n-6) nd nd nd nd 
22:5(n-3)/24:0 0.135 0.168 0.149 0.169 
22:6 (n-3) 0.221 0.222 0.085 0.105 
Σ PUFA 23.644 20.663 26.275 26.845 
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Table 4. Comparison of Fatty Acid ratios from Human Milk and Infant Formula Sources.2These Calculations are Based on the 
Assumption that the GLC Peaks Representing Mixtures of 20:5 (n-3) + 22:0 and of 22:5 (n-3) + 24:0 Consist of Equal 
Amounts of Each Component 
a. Human Milk 
Donor 1 2 3 4 5 6 7 
FA mole % mole % mole % mole % mole % mole % mole % 
                
Σ C18 PUFA 18.293 18.660 17.878 19.634 22.393 16.126 24.367 
Σ C20 PUFA 0.926 0.963 1.336 0.927 1.375 1.027 1.381 
Σ C22 PUFA 0.255 0.220 0.294 0.217 0.583 0.414 0.595 
                
ratio (SFA+MUFA)2/PUFA 4.11 4.01 4.09 3.79 3.07 4.64 2.78 
                
Σ n-6 PUFA 17.907 18.233 18.263 19.636 22.361 15.423 23.765 
Σ n-3 PUFA 1.378 1.264 1.056 0.978 1.809 2.022 2.335 
Ratio2n6/n3 12.99 14.42 17.29 20.08 12.36 7.628 10.18 
b. Infant Formula 
Formula Goodstart Enfamil SmlcBaby SmlcIso 
FA mole % mole% mole% mole% 
          
Σ C18 PUFA 22.429 19.293 25.386 25.907 
Σ C20 PUFA 0.741 0.823 0.512 0.508 
Σ C22 PUFA 0.324 0.335 0.183 0.220 
          
ratio (SFA+MUFA2/PUFA 3.23 3.84 2.81 2.72 
          
Σ n-6 PUFA 21.174 18.406 23.629 24.127 
Σ n-3 PUFA 2.320 2.045 2.451 2.508 
Ratio2n6/n3 9.127 9.000 9.641 9.620 
 
DISCUSSION 
 This study compared the lipid profiles of seven milk 
samples obtained from American milk banks with four types 
of infant formulas with regard to cholesterol and triglyceride 
levels and fatty acid composition. The TG content of the 
human milk and infant formulas were comparable but the 
cholesterol content of the latter was about 50% higher than 
that found for the human samples. Our human cholesterol 
milk data is about half that reported by Huisman et al. [8] 
which may be a reflection of the different diets consumed by 
American and Dutch women and/or a change in eating habits 
between these groups over the last 17 years.  
 The fatty acid profiles of our human milk samples were 
quite similar to those reported for European women [8, 9, 
12] and it seems unlikely that the typical pasteurization pro-
cess used by milk banks [2] has any influence on the lipid 
profile of breast milk samples. In addition, the fatty acid 
composition of the American infant formulas tested in this 
study were comparable to those reported for Dutch, German 
and Spanish commercial infant formulas [8, 9, 13]. In con-
trast to our human PUFA profiles, no CLA [a family of iso-
mers with beneficial effects [14, 15] was detected in our in-
fant formula products. However, since many dairy and meat 
products contain CLA [16], once the infant is weaned from 
infant formula, these known CLA-containing foods are  
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common dietary components. A similar concern for the ab-
sence of 22:4 (n-6), an essential precursor to very long-chain 
(n-6) PUFAs needed for normal spermatogenesis and fertili-
ty [17], in any of the infant formulas may be forestalled in 
view of the presence of 20:4 (n-6), the precursor to 22:4 (n-
6).A number of reports have shown that both 20:4 (n-6) and 
22:6 (n-3) levels in human milk correlate positively with 
infant growth and development [18, 19]. Our data indicate 
that the 20:4 (n-6) and 22:6 (n-3) mole % ranges for the hu-
man samples (0.22-0.59 and 0.054-0.29 respectively) are 
quite comparable to those found for the infant formulas 
(0.34-0.63 and 0.085-0.22 respectively).  
 n-6 PUFAs and n-3 PUFAs are precursors to different 
oxidized metabolites (e.g. eicosanoids) that tend to have op-
posing biological effects in such diverse activities as cellular 
aggregation, immunological and inflammatory processes 
[20]. Consequently, the n-6 PUFA/n-3 PUFA ratio (n6/n3) 
has usually been used as a marker to indicate which of these 
metabolites are expected to be dominant [21]. Our studies 
indicate that this n6/n3 ratio for the human milk (mean 13.6) 
was significantly (about 50%) higher than that found for the 
infant formulas.  
CONCLUSION 
 Despite the fact that the World Health Organization rec-
ommends that mothers breastfeed their infants for the first 6 
months, certain circumstances may make the mother’s own 
milk unavailable. Alternative choices are breast milk from 
milk banks or commercial formula though each option repre-
sents different benefits and risks [2, 3]. Our small study indi-
cates that there are small, yet significant, differences in the 
lipid composition (i.e. cholesterol and CLA contents and 
certain fatty acid profiles) of milk bank breast milk and in-
fant formulas but that these differences are not sufficient to 
prioritize either nutritional source.  
ABBREVIATIONS 
CLA = Conjugated linoleic acid 
FAME = Fatty acid methyl ester 
MUFA = Mono-unsaturated fatty acid 
PUFA = Poly-unsaturated fatty acid 
SFA = Saturated fatty acid 
TG = Triglyceride 
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